Source link : https://www.newshealth.biz/health-news/fasenra-recommended-in-europe-for-rare-blood-vessel-disorder/
The European Commission has approved the Committee for Medicinal Products for Human Use (CHMP) recommendation to change the terms of marketing authorization for Fasenra (benralizumab). It can now also be used as an add-on treatment in adults with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA). Its original indication is as an add-on maintenance treatment […]
Author : News Health
Publish date : 2024-10-30 12:14:12
Copyright for syndicated content belongs to the linked Source.